Engineering Conferences International

ECI Digital Archives
Integrated Continuous Biomanufacturing II

Proceedings

Fall 11-2-2015

BioSC® predict simulation software: FLexibility and
optimization of your multi-column process
Fabien Rousset
fabien.rousset@novasep.com, fabien.rousset@novasep.com

Follow this and additional works at: http://dc.engconfintl.org/biomanufact_ii
Part of the Biomedical Engineering and Bioengineering Commons
Recommended Citation
Fabien Rousset, "BioSC® predict simulation software: FLexibility and optimization of your multi-column process" in "Integrated
Continuous Biomanufacturing II", Chetan Goudar, Amgen Inc. Suzanne Farid, University College London Christopher Hwang,
Genzyme-Sanofi Karol Lacki, Novo Nordisk Eds, ECI Symposium Series, (2015). http://dc.engconfintl.org/biomanufact_ii/122

This Conference Proceeding is brought to you for free and open access by the Proceedings at ECI Digital Archives. It has been accepted for inclusion in
Integrated Continuous Biomanufacturing II by an authorized administrator of ECI Digital Archives. For more information, please contact
franco@bepress.com.

BATCH

CONTINUOUS

BioSC®Lab and Predict® simulation software:
flexibility and optimization of your multi-column process
Fabien Rousset Ph.D, Head of Product Development Manager
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Introduction

BioSC® Lab

Biopharma companies often need to
flexibly accommodate large to small
volume of biologics, preferably within the
same manufacturing facilities. They are
developing alternative processes that
bring continuous manufacturing operations with consistent product quality,
reduced equipment size, high productivity,
streamlined process flow, low process
cycle times and reduced capital and
operating cost. Many reasons that explain
the growing interest in realizing the benefits
of continuous processing in biologics
manufacturing that are more and more
encouraged by guidance as FDA mentioned
in recent conference presentations.
The ability to rapidly adjust production
capacity to accommodate fluctuating
and/or mis-forecasted market demands,
reducing the cost impacted by growing
competition from biosimilar products and
by government regulations, concerning
about the sustainability of the traditional
batch manufacturing facility model
involving DSP trains with large
chromatographic columns, the consistent
improvements in upstream product and
the associated DSP limitation with current
technology, leaded R&D departments
to accelerate the introduction of continuous
process culture in their PD phase.
Hybrid systems (combination of continuous
and batch operations) and fully integrated
continuous process are developed now
for many biologics such mAbs, recombinant
proteins and vaccines…Continuous
operations require software and hardware
systems that provide a high degree of
automation, PAT approach and possibly in
silico simulation that predict the evolution
of the system to make the integration
easier and faster.
All these needs and requirements are
present in Novasep’s unique lab equipment
called BioSC® Lab to accommodate the
process development of continuous
operation from lab to large scale with a
smart simulation software called BioSC®
Predict to facilitate and fasten the process
of improving overall operation efficiency.

BioSC® PredictTM

Mass Flowmeter
to control
your process

1 to 6 columns/devices
for the maximum of
flexibility (5-16mmID)

Collect all your product
with UV cut
on elution line

2 UV detectors
to follow
your target molecule

8 inlets for line
segregation and
system efficiency

6 magnetic column
holders/clamp

BioSC® Predict is a simulation software using optimization algorithms (lumped kinetics model) to
provide the most adapted operational conditions (number and geometry of columns, flowrates,
etc.). With few batch data, the user can play with the optimization parameters to quickly generate
a large amount of data on the chromatographic system (media and protein) and select the best
process conditions. Replacing tens of experiments, BioSC® Predict saves your time and resources
in process development.

2 pH/Cond sensors
to detect buffer
location

Secured design with
2 Block of valves to
limit contamination
Interrupted and
continuous loading

Electrical cabinet
included
in the design

8 Robust pumps
1-30mL/min

Linear gradient
for process steps
Real-time
supervision
(steady state control)

Simulation and
optimisation
BioSC® Predict
software

Condensed
design for
benchtop use

2-ways valves distribution
that allows adaptability
to your needs

Various processes possible with BioSC®Lab

Batch process

Parallel Batch

Continuous chromatography
from 2 to 6 columns

Continuous Process

PAT Approach:
• UV detection (190-700nm):
- after a column (IPC for process deviation)
- elution line for UV-cut and product quality control
• Flow-rate with mass flow-meter for mass balance control
• Temperature on the first column for process control
• pH and conductivity sensors for process control
• Pressure sensors for cycling control

Time/volume–based recipe to:
• Avoid process control at signal saturation
where submitted non-linear Beer Lamber’s law
• Maintain the system design
(no UV cell change required)
• Allow maximisation of buffer & media consumption
at saturation compared to UV-based recipe
• Less risky with UV detector accuracy independancy

Application to a mAb Platform

Conclusion

A purification process of monoclonal antibodies based on two continuous chromatography steps (capture and intermediate ion exchange) has been developed and optimized
using batch data. Significant gains have been observed on productivity, buffer consumption and on the volume of resin required. Based on these results, a chained process
from capture to polishing steps has been implemented. This process demonstrated significantly better performance compared to the batch equivalent while reaching the
qualitative specifications.
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The development of a batch chromatography step typically
requires many experiments to be designed and performed in the
lab before finding the right operating conditions. This work costs
time (up to several weeks) and money while consuming precious
materials which are often limited. BioSC® Predict provides the
user with a solution to reduce this development step to 2-4
experiments and perform the rest in-silico. By providing the
software with a few data generated from common batch
chromatography experiments, the user can generate a first
continuous chromatography recipe and directly run it on
BioSC® Lab equipment. The software will also generate a first
performance comparison between batch and continuous
chromatography.
Since the implementation of continuous processing is a big
challenge right now, the design of the BioSC® Lab has been
accomplished to introduce flexibility in the design of SMCC
recipes, with a user-friendly environment associated with a
PAT approach that enables safe and robust process development.
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